Home › Neuroblastoma › Florida › Gainesville
Neuroblastoma clinical trials in Gainesville, FL
6 studies for Neuroblastoma are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- University of Florida, Gainesville
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- University of Florida, Gainesville
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RecruitingPhase 2
- University of Florida, Gainesville
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RecruitingPhase 1/2
- University of Florida, Gainesville
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Minneapolis, MN8 studies
- Atlanta, GA7 studies
Other studies in Gainesville
- Heart Failure13 studies
- Parkinson's Disease13 studies
- Type 1 Diabetes12 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer10 studies
- Colorectal Cancer9 studies
- Cardiovascular Disease9 studies
- Cancer (all types)9 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Acute Myeloid Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.